Various mediators, including inflammatory cytokines and prostaglandins, can affect paracellular TJs and vesicular transport in ECs and are involved in multiple mechanisms (133, 134)
Because it is not a stimulant, it may be suitable for people who cannot take medications like phentermine
Clinical trials are still needed to validate their safety and efficacy in human patients before they can be widely used in AD therapy
However, having commercial insurance provides opportunity for: Potentially lower medication costs if coverage approved (copay instead of cash-pay) Insurance concierge support to navigate authorization process Possibility of manufacturer savings programs Note: Ro cannot assist with most government insurance programs (Medicare, Medicaid, VA, TRICARE), though FEHB beneficiaries can receive assistance
Clinical and psychometric assessment scores were better, and clinician-determined improvements were greater in supplement users than in placebo groups [16]